UK marketing authorisations for IOPIDINE® (apraclonidine)
UK marketing authorisations for IOPIDINE® (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment...
Source: globenewswire.com
Glaucoma Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Glaucoma Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Glaucoma Studies Today - Breaking & Trending Today
UK marketing authorisations for IOPIDINE (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment expected to lead to increase in patients' need for product
UK marketing authorisations for IOPIDINE (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment expected to lead to increase in patients' need
Source: finanznachrichten.de
World-class health research at UCL awarded £145M
UCL is the research partner of the NIHR UCLH BRC, awarded £90m, the NIHR Great Ormond Street Hospital (GOSH) BRC, awarded £35m, and the NIHR Moorfields BRC, awarded £20m. The total award to UCL is the most of any UK university and signals the strength of UCL’s world-class translational research and scientific discovery.
Source: sciencebusiness.net